Telik Settles Securities Class Action For $5M
Telik Inc. has agreed to pay $5 million to settle a securities class action accusing the biopharmaceutical company of hyping its failed cancer treatment Telcyta and inflating the company stock....To view the full article, register now.
Already a subscriber? Click here to view full article